InMed Technologies is committed to research and drug discovery. We believe we can make a difference; we have devoted vast resources to discover and develop the highest quality, innovative and specific nutraceuticals, nutritional supplements and cosmeceuticals.
Research can be conducted in a number of different ways for many different purposes, from clinical trial studies in large patient populations to bioavailability studies on absorption in humans. Research must have controls and baseline rates to show correlations of benefit and effectiveness. Research also needs to have safety mechanisms and professionals conducting the research to be highly experienced.
Regardless of whether a research program is on a nutraceutical or pharmaceutical product, the research protocols and stringent controls must be the same.
Research focus at InMed Technologies
Some may argue that nutraceutical research does not need the same controls as pharmaceutical research, because it is generally safe or natural. However, human bioindividuality shows us that people may or could react differently.
Being able to conduct scientific and medical research allows InMed Technologies to safely innovate. It also allows us to educate our clients, which in turn ensures confidence in the clinic.
InMed Technologies is partly owned by an Australian company, Medlab (www.medlab.co), a certified biological research center, specializing in the development of novel therapeutics from bacteria. Professor Luis Vitetta heads Medlab’s research, a peer reviewed, invitational speaker renowned for his work in probiotics and gut health. Professor Vitetta is partnered with David Rutolo, PhD, senior officer at InMed Technologies, a renowned expert in small particle absorption (patent holder), and product fabrication.
This partnership allows InMed Technologies to conduct research under the rigors of pharmaceutical development. InMed Technologies patent portfolio is an outcome of research, allowing us to strongly differentiate ourselves from other companies. We believe we can serve the needs of healthcare professionals and patients better than anyone else in the business.
Full publications associated with Medlab
itetta L, Gobe G. Uremia and Chronic Kidney Disease: The Role of Probiotics / Prebiotics. Molecular Nutrition and Food Research 2013; Mar 1. doi: 10.1002/mnfr.201200714.
Marx WM, Teleni LX, McCarthy AL, Vitetta L, McKavanagh D, ThomsonT, IsenringE. Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature review. Nutrition Reviews 2013; 71(4):245-54.
Schloss JM,Colosimo M, Airey C, Vitetta L. Nutraceuticals and Chemotherapy Induced Peripheral Neuropathy (CIPN): a Systematic Review. Clinical Nutrition 2013; doi:pii: S0261-5614(13)00107-6. 10.1016/j.clnu.2013.04.007.
Palacios T, Coulson S, Butt H, Vitetta L. The Gastrointestinal Microbiota and Multi-Strain Probiotic Therapy: In Children and Adolescent Obesity. Advances Integrative Medicine 2014;1:2-8.
Bella CJ, Coulson S, Vitetta L. Is co–prescribing a multi–strain probiotic the simple solution for treating and preventing Proton Pump Inhibitor (PPIs) induced Clostridium difficile Associated Diarrhoea (CDAD) while maintaining evidence based pharmacotherapy? Submitted Advances Integrative Medicine 2014;1:52-54.
Gray B, Vitetta L, Davies WP. Waist circumference and liver enzymes better predictors of adiponectin levels than BMI in overweight and obese adults. Nutrition Research 2013;33(10):781-788.
ShingCM, PeakeJ,Lim CL, Briskey D, Walsh NP, Fortes MB,Ahuja K, Vitetta L. Probiotic supplementation improves exercise performance in the heat. European Journal of Applied Physiology. 2013; 114(1):93-103.
Gray B, Steyn F, Davies PSW,Vitetta L. Omega-3 fatty acids: A review of the effects on adiponectin and leptin and potential implications for obesity management. European Journal of Clinical Nutrition. 2013 Oct 16. doi: 10.1038/ejcn.2013.197. [Epub ahead of print]
Vitetta L, Alford H. The Pharmacobiotic Potential of the Gastrointestinal Tract Micro-Biometabolome–Probiotic Connect:A Brief Commentary. Drug Development Research 2013;74:353-359.
Vitetta L, Linnane AW, Gobe GC. From the Gastrointestinal Tract (GIT) to the Kidneys: Live Bacterial Cultures (Probiotics) Mediating Reductions of Uremic Toxin Levels via Free Radical Signaling. Toxins 2013;5(11): 2042-2057.
Vitetta L, Couslon S, Linnane AW, Butt H. The Gastrointestinal Microbiome and Musculoskeletal Diseases: Is There a Role for Probiotics and Prebiotics? Pathogens 2013;2:606-626;
Conference Presentations and Proceedings
Palacios T, Coulson S, Butt H, Leong G, Dahiya R, Vitetta L. Gut Microbiota and Metabolic Syndrome: How a Multi-Strain Probiotic may Influence Biomarkers in Obese Adolescents. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.
Coulson S, Palacios T, Butt H, Leong G, Dahiya R, Vitetta L. The Role of Gut Microbiota in Non-Alcoholic Fatty Liver Disease: The Efficacy of a Multi-Strain Probiotic in Obese Adolescents. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.
Steels E, Rao A,Coulson S, Vitetta L. A phase II randomised double–blind placebo–controlled clinical trial investigating the efficacy and safety of a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.
Schloss J, Colosmio M, Linnane AW, Masci P, Vitetta L. B Vitamin Status In Cancer Patients Administered Chemotherapy. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.
Marx W,Ried K, Sali A, Teleni L, McCarthy A, Vitetta L, McKavanagh D, Thomson D, Isenring E. Is Ginger Supplementation Effective In Ameliorating Chemotherapy-Induced Nausea And Vomiting? 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.
Vitetta L. The Importance of Translational Research in Complementary and Alternative Medicines [CAMs]: Within the Realm of Biological Plausibility. ARCS, 2013. Sydney, Australia.
Full publications associated with Medlab
Vitetta L, Linnane AW. Endocellular regulation by free radicals and hydrogen peroxide: key determinants of the inflammatory response. Inflammopharmacology. 2014 Feb 22.
Scholoss, J, Vitetta L. Antioxidants to Abrogate Free Radicals: a billion dollar industry based on a chimeric notion without biological plausibility. New insights to challenge currently held beliefs. Australian Journal of Herbal medicine 2014;26(1):4-6, 33.
Vitetta L, Briskey B,Alford H, Hall S, Coulson S. Probiotics in the Regulation of the Gastrointestinal Inflammatory Response: A Critical Review. Inflammopharmcology 2014. Mar 2014.
Vitetta L, Linnane AW. Endocellular Regulation of Free Radicals and Hydrogen Peroxide: Key Determinants of the Inflammatory Response. Inflammopharmacology 2014;22(2):69-72.
Vitetta L, Manuel R, Zhou JY, Linnane AW, Hall S. Live Probiotic Cultures and the Overarching Influence on End-Organ Function. Pharmaceuticals (Basel).
Vitetta L, Hall S, Linnane AW. Live Probiotic Cultures and the Gastrointestinal Tract: Symbiotic Preservation of Tolerance Whilst Attenuating Pathogenicity. Frontiers in Cellular and Infection Microbiology.
Conference Presentations and Proceedings
Schloss J, Colosmio M, Linnane AW, Masci P, Vitetta L. A Randomised Placebo-Controlled Clinical Trial Assessing The Efficacy And Safety Of Supplementation With B Vitamins To Reduce The Incidence Of Chemotherapy-Induced Peripheral Neuropathy [Cipn], Final Results. 4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.
Palacios T, Coulson S, Butt H, Vitetta L. The Effect Of Microbiota-Based Interventions And Metformin In Metabolic And Inflammatory Biomarkers In Adults With Type 2 Diabetes Mellitus (T2DM). 4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.
Marx W, McCarthy AL, Ried K, Vitetta L, McKavanagh D, Thomson D, Sali A, Isenring L. Ginger–Mechanism Of Action In Chemotherapy‐Induced Nausea And Vomiting: A Review. 4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.
Vitetta L. The gastrointestinal tract microbiome and the metabolism of herbal compounds such as trigonella foenum-graecum extract. The 4th International Symposium on Curry and Spice (April 24, 2014) in Seoul, South Korea.
Vitetta L. Probiotics, the gastrointestinal tract microbiome and musculoskeletal diseases. International Probiotic Association World Congress. May 9-10, 2014, Athens, Greece. In: Beneficial Microbes 5 (suppl 1): 23.